Big Pharma Split Stock Analysis

Big Stock Analysis Notes

The company has price-to-book ratio of 0.95. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Big Pharma Split last dividend was issued on the 28th of June 2024. Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada. BIG PHARMA operates under Asset Management classification in Canada and is traded on Toronto Stock Exchange. To find out more about Big Pharma Split contact the company at 416-649-4541 or learn more at https://www.harvestportfolios.com/closed-end-funds.

Big Pharma Split Investment Alerts

Big Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Big Pharma's market, we take the total number of its shares issued and multiply it by Big Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Big Profitablity

The company has Profit Margin (PM) of (2.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.51 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.51.

Management Efficiency

As of the 1st of December 2024, Return On Tangible Assets is likely to grow to -0.005. In addition to that, Return On Capital Employed is likely to grow to -0.0086. At this time, Big Pharma's Total Assets are very stable compared to the past year. As of the 1st of December 2024, Debt To Assets is likely to grow to 0.42, while Net Tangible Assets are likely to drop about 19.7 M. Big Pharma's management efficiency ratios could be used to measure how well Big Pharma manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of December, Big Pharma shows the risk adjusted performance of (0.10), and Mean Deviation of 0.6512. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Big Pharma, as well as the relationship between them.

Big Pharma Split Price Movement Analysis

Big Pharma Outstanding Bonds

Big Pharma Predictive Daily Indicators

Big Pharma Forecast Models

Big Pharma's time-series forecasting models are one of many Big Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Big Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Big Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Big shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Big Pharma. By using and applying Big Stock analysis, traders can create a robust methodology for identifying Big entry and exit points for their positions.

Big Pharma financial ratios help investors to determine whether Big Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Big with respect to the benefits of owning Big Pharma security.